irbm
Silver Sponsor
Advaxia Biologics is a specialized CDMO located near Rome, Italy, focused on the GMP manufacturing of viral vector-based biologics for gene therapy and vaccine clinical programs.
Advaxia supports AAV, LVV, MVA, and oncolytic viruses through both standalone and integrated services, including:
- Manufacturing Process Development
- Analytical Method Development and Validation
- QC Testing and Stability Studies in Compliance with ICH Guidelines
- Aseptic Fill & Finish (BSL-2) for Clinical Supply
End-to-end, integrated development and manufacturing support is available for adenovirus (AdV) programs.
Advaxia has a 100% GMP batch release track record and extensive experience delivering clinical lots under EMA, FDA, and MHRA standards, including for programs targeting HIV, Ebola, and COVID-19.
For more information, visit our website: www.advaxia.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events